Tag: Liver Disease: Misc.
COVID-19 Tied to Progression of Chronic Liver Disease
About one in five patients with preexisting chronic liver disease develop progressive cholestasis after severe COVID-19
Risk for Existing, Incident T2D High in Children With NAFLD
Risk factors for incident T2D include female gender, BMI z-score, and more severe liver histology, including steatosis grade, fibrosis stage
Psoriasis Tied to Higher Risk for Nonalcoholic Fatty Liver Disease
Authors say this association may be relevant to psoriasis management with some antipsoriatic agents
Drug Therapy for AUD May Cut Risk for Alcohol-Related Liver Disease
Pharmacotherapy for alcohol use disorder linked to reduced incidence of hepatic decompensation in patients with cirrhosis
DDW: Cardiovascular Disease More Common in Lean NAFLD Patients
Findings independent of other risk factors like age, sex, race, smoking status, diabetes, hypertension, and dyslipidemia
Living-Donor Liver Transplant Promising for CRC With Liver Mets
Recurrence-free survival of 62 percent, overall survival of 100 percent at 1.5 years after LDLT in select patients
Exercise May Lower Clotting Risk in Patients With NASH
Exercise benefits extend beyond liver-related outcomes, independent of weight loss or dietary change
NAFLD May Raise Risk for Severe Hypoglycemia in T2DM
Association independent of obesity status seen in patients with type 2 diabetes and nonalcoholic fatty liver disease
NAFLD Risk Up in Women With Long, Irregular Menstrual Cycles
Risk for NAFLD increased with long or irregular cycles in women younger than 40 years after adjustment for age, BMI, insulin resistance, other confounders
Health Care Usage Down With DAA Therapy for Chronic Hep C
Rates of hospitalizations, liver-related ED visits lower for patients with sustained virological response to direct-acting antiviral therapy
